# Adial Pharmaceuticals, Inc.: filings

ADIL · Nasdaq · CIK 1513525 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adil.md) · [Financials](/companies/adil/financials.md) · [Filings](/companies/adil/filings.md) · [Insiders](/companies/adil/insiders.md)

## Reports and events: 235 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 153, 4 98, CORRESP 36, EFFECT 27, 10-Q 25, UPLOAD 24, D 19, 424B3 17, 3 16, S-1/A 13, 424B5 11, DEF 14A 11, S-3 11, S-1 10, S-8 9, 10-K 8, DEFA14A 7, FWP 6, POS AM 6, SC 13D/A 6, PRE 14A 5, SC 13G 5, SC 13G/A 5, ARS 4, SC 13D 4, 8-K/A 3, DRS 3, DRSLTR 3, SCHEDULE 13G 3, 10-Q/A 2, 424B4 2, 4/A 2, DEFR14A 2, DRS/A 2, S-3/A 2, SCHEDULE 13G/A 2, 25-NSE 1, 8-A12B 1, 8-A12B/A 1, CERT 1, NT 10-Q 1, NT 10-Q/A 1, PRER14A 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 16:30 ET | [8-K](/filings/0001213900-26-113337.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-113337 |
| 2026-10-21 | 20:25 ET | [10-Q/A](/filings/0001213900-26-111121.md) | Quarterly report, amended, period 2026-06-30 | 0001213900-26-111121 |
| 2026-10-16 | 17:15 ET | [8-K](/filings/0001213900-26-110349.md) | 8.01 Other events | 0001213900-26-110349 |
| 2026-10-02 | 16:16 ET | [8-K](/filings/0001213900-26-106395.md) | 8.01 Other events | 0001213900-26-106395 |
| 2026-09-18 | 16:27 ET | [8-K](/filings/0001213900-26-101434.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-101434 |
| 2026-09-16 | 17:08 ET | [8-K](/filings/0001213900-26-100574.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100574 |
| 2026-08-25 | 16:33 ET | [8-K](/filings/0001213900-26-093544.md) | 3.02 Unregistered sale of equity | 0001213900-26-093544 |
| 2026-08-24 | 16:05 ET | [DEF 14A](/filings/0001213900-26-093019.md) | Proxy statement, period 2026-09-17 | 0001213900-26-093019 |
| 2026-08-21 | 17:17 ET | [8-K](/filings/0001213900-26-092690.md) | 3.01 Delisting notice | 0001213900-26-092690 |
| 2026-08-17 | 07:17 ET | [8-K](/filings/0001213900-26-090482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090482 |
| 2026-08-14 | 16:07 ET | [10-Q](/filings/0001213900-26-090051.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090051 |
| 2026-08-13 | 17:25 ET | [8-K](/filings/0001213900-26-089270.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001213900-26-089270 |
| 2026-08-11 | 21:13 ET | [8-K/A](/filings/0001213900-26-087439.md) | 9.01 Financial statements and exhibits | 0001213900-26-087439 |
| 2026-06-11 | 12:43 ET | [8-K](/filings/0001213900-26-067711.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-067711 |
| 2026-05-11 | 08:40 ET | [8-K](/filings/0001213900-26-054219.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054219 |
| 2026-05-08 | 16:21 ET | [10-Q](/filings/0001213900-26-053907.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053907 |
| 2026-04-09 | 17:00 ET | [8-K](/filings/0001213900-26-042057.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-042057 |
| 2026-03-06 | 08:15 ET | [8-K](/filings/0001213900-26-024336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-024336 |
| 2026-03-05 | 17:03 ET | [10-K](/filings/0001213900-26-024175.md) | Annual report, period 2025-12-31 | 0001213900-26-024175 |
| 2026-03-03 | 08:17 ET | [8-K](/filings/0001213900-26-022718.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-022718 |
| 2026-02-24 | 09:06 ET | [8-K](/filings/0001213900-26-019639.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019639 |
| 2026-02-04 | 16:30 ET | [8-K](/filings/0001213900-26-012274.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-012274 |
| 2026-01-06 | 16:15 ET | [8-K](/filings/0001213900-26-001790.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-001790 |
| 2026-01-06 | 16:15 ET | [DEF 14A](/filings/0001213900-26-001792.md) | Proxy statement, period 2026-02-26 | 0001213900-26-001792 |
| 2025-12-01 | 16:05 ET | [8-K](/filings/0001213900-25-116666.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116666 |
| 2025-11-14 | 08:35 ET | [8-K](/filings/0001213900-25-110385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-110385 |
| 2025-11-13 | 16:07 ET | [10-Q](/filings/0001213900-25-109979.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109979 |
| 2025-09-16 | 08:05 ET | [8-K](/filings/0001213900-25-087925.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087925 |
| 2025-09-03 | 08:48 ET | [8-K](/filings/0001213900-25-083719.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-083719 |
| 2025-08-14 | 08:35 ET | [8-K](/filings/0001213900-25-076085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076085 |
| 2025-08-13 | 16:17 ET | [10-Q](/filings/0001213900-25-075695.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075695 |
| 2025-08-01 | 16:51 ET | [8-K](/filings/0001213900-25-070671.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-070671 |
| 2025-08-01 | 16:34 ET | [8-K](/filings/0001213900-25-070642.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-070642 |
| 2025-07-16 | 08:30 ET | [8-K](/filings/0001213900-25-064467.md) | 8.01 Other events | 0001213900-25-064467 |
| 2025-07-10 | 16:30 ET | [8-K](/filings/0001213900-25-062800.md) | 8.01 Other events | 0001213900-25-062800 |
| 2025-06-18 | 17:10 ET | [8-K](/filings/0001213900-25-055700.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-055700 |
| 2025-06-16 | 17:20 ET | [8-K](/filings/0001213900-25-054839.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001213900-25-054839 |
| 2025-06-13 | 17:26 ET | [S-1/A](/filings/0001213900-25-054387.md) | Registration statement, amended | 0001213900-25-054387 |
| 2025-06-10 | 17:28 ET | [DEF 14A](/filings/0001213900-25-053170.md) | Proxy statement, period 2025-07-24 | 0001213900-25-053170 |
| 2025-06-06 | 08:34 ET | [S-1](/filings/0001213900-25-051752.md) | Registration statement | 0001213900-25-051752 |
| 2025-05-30 | 16:01 ET | [8-K](/filings/0001213900-25-049451.md) | 3.01 Delisting notice | 0001213900-25-049451 |
| 2025-05-15 | 08:40 ET | [8-K](/filings/0001213900-25-043733.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-043733 |
| 2025-05-15 | 08:35 ET | [8-K](/filings/0001213900-25-043730.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043730 |
| 2025-05-14 | 16:02 ET | [10-Q](/filings/0001213900-25-043281.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043281 |
| 2025-05-07 | 17:18 ET | [8-K](/filings/0001213900-25-040724.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-040724 |
| 2025-05-01 | 16:09 ET | [8-K](/filings/0001213900-25-038442.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-038442 |
| 2025-03-21 | 16:15 ET | [8-K](/filings/0001013762-25-000999.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-000999 |
| 2025-03-07 | 16:15 ET | [8-K](/filings/0001213900-25-021738.md) | 3.01 Delisting notice | 0001213900-25-021738 |
| 2025-03-04 | 08:57 ET | [8-K](/filings/0001213900-25-019779.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-019779 |
| 2025-03-04 | 08:49 ET | [10-K](/filings/0001213900-25-019771.md) | Annual report, period 2024-12-31 | 0001213900-25-019771 |

Page 1 of 5. [Older](/companies/adil/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 20:45 ET. No prices; not investment advice.